Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1999 May;80(5):421-3.
doi: 10.1136/adc.80.5.421.

A randomised controlled trial to assess the relative benefits of large volume spacers and nebulisers to treat acute asthma in hospital

A L Dewar  1 , A Stewart, J J Cogswell, G J Connett
Affiliations
Clinical Trial

A randomised controlled trial to assess the relative benefits of large volume spacers and nebulisers to treat acute asthma in hospital

A L Dewar et al. Arch Dis Child. 1999 May.

Abstract

Objectives: To compare the clinical effectiveness, acceptability, and cost benefit of administering beta2 agonists by means of a metered dose inhaler and large volume spacer with conventional nebulisers to children admitted to hospital with acute asthma.

Methods: A randomised controlled trial was conducted over five months. Sixty one children older than 3 years admitted to a large teaching hospital and a district general hospital with acute asthma completed the study. Children received either 5 mg of salbutamol up to one hourly by jet nebuliser, or up to 10 puffs of salbutamol 100 microg by means of a metered dose inhaler and spacer up to one hourly.

Results: Median hospital stay was 40 hours in the nebuliser group and 36.5 hours in the spacer group. Asthma disability scores at two weeks after discharge were significantly improved in the spacer group. Drug costs were pound 14.62 less for each patient in the spacer group.

Conclusions: Large volume spacers are an acceptable, cost effective alternative to nebulisers in treating children admitted with acute asthma, provided that the children can use the mouthpiece, and symptoms are not severe. Their use facilitates effective home treatment by parents, with subsequent reduction in morbidity and re-admission rates.

PubMed Disclaimer

References

    1. Eur J Respir Dis. 1986 Aug;69(2):109-13 - PubMed
    1. Pediatrics. 1989 Apr;83(4):507-12 - PubMed
    1. Am J Dis Child. 1989 Jun;143(6):678-81 - PubMed
    1. Med J Aust. 1989 Oct 2;151(7):406-8 - PubMed
    1. Arch Dis Child. 1990 Jul;65(7):779-81 - PubMed